Non-nucleoside reverse transcriptase inhibitors

Details for Australian Patent Application No. 2007314521 (hide)

Owner Merck & Co., Inc.

Inventors Poehnelt, Rebecca A.; Williams, Theresa M.; Obligado, Vanessa E.; Zhang, Xu-Fang

Agent Spruson & Ferguson

Pub. Number AU-A-2007314521

PCT Pub. Number WO2008/054605

Priority 60/849,902 06.10.06 US

Filing date 2 October 2007

Wipo publication date 8 May 2008

International Classifications

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

C07D 207/337 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/054605 Priority application(s): WO2008/054605

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007314522-High affinity human antibodies to human ILl-4 receptor

2007314519-IL-17 receptor A antigen binding proteins